← Return to FDA Expands Use Of Keytruda for NSCLC

Discussion

FDA Expands Use Of Keytruda for NSCLC

Lung Cancer | Last Active: May 6, 2019 | Replies (12)
Comment receiving replies
@merpreb

@alamogal635- Good morning. I'm confused by your last statement, " but is fainting in its potentials IMHO"
Can you unconfuse me?

Jump to this post

Replies to "@alamogal635- Good morning. I'm confused by your last statement, " but is fainting in its potentials..."
alamogal635 | @alamogal635 | May 5, 2019

@merpreb Sorry about that. Told you all I need a proof reader. more exactly, need a new glasses RX! I mean to write fascinating in its potentials. I am thinking of not just with cancer research, but in uses with such issues as MS and others such diseases. Will get my vision checked out next month. Maybe it's time for getting cataracts removed. Anyway, will check my writing meter from now on.

VIEW AND REPLY